← Evidence map

ReviewFrontiers in oncology2026

Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents.

Orel Slotki-Itzchakov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Breaking the ERK1/2 negative feedback loop: avoiding reactivation and acquisition of resistance by ERK1/2 to anti-cancer agents. | OpenQuestion